New Releases from NCBI BookshelfComparative Effectiveness of Focused Ultrasound Therapy for Movement Disorders.Comparative Effectiveness of Focused Ultrasound Therapy for Movement Disorders.
Post Content
December 18, 2025
Uncategorized
New Releases from NCBI BookshelfPertuzumab: Therapeutic area: Early-stage breast cancer: Reimbursement Review [Internet].Pertuzumab: Therapeutic area: Early-stage breast cancer: Reimbursement Review [Internet].
HER2-positive breast cancer is a subtype of breast cancer characterized by overexpression of the HER2 protein, which is associated with
Uncategorized
New Releases from NCBI BookshelfMirikizumab (Omvoh): Indication: For the treatment of adult patients with moderately to severely active Crohn’s disease who have had an inadequate response, loss of response, or were intolerant to either conventional therapy or a biologic treatment: Reimbursement Recommendation [Internet].Mirikizumab (Omvoh): Indication: For the treatment of adult patients with moderately to severely active Crohn’s disease who have had an inadequate response, loss of response, or were intolerant to either conventional therapy or a biologic treatment: Reimbursement Recommendation [Internet].
Canada’s Drug Agency (CDA-AMC) recommends that Omvoh be reimbursed by public drug plans for the treatment of moderately to severely
